You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-Histone Methyltransferase (HMTase)-GSK3368715 dihydrochloride
GSK3368715 dihydrochloride

Chemical Structure : GSK3368715 dihydrochloride

CAS No.: 1628925-77-8

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride)

Catalog No.: PC-21842Not For Human Use, Lab Use Only.

GSK3368715 (EPZ019997, GSK-3368715) dihydrochloride is a potent, reversible and SAM uncompetitive type I PRMT inhibitor with Kiapp of 1.5 to 81 nM for PRMT1, 3, 4, 6, and 8.

Packing Price Stock Quantity
5 mg $138 In stock
10 mg $218 In stock
25 mg $388 In stock
50 mg $588 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GSK3368715 (EPZ019997, GSK-3368715) dihydrochloride is a potent, reversible and SAM uncompetitive type I PRMT inhibitor with Kiapp of 1.5 to 81 nM for PRMT1, 3, 4, 6, and 8.
GSK3368715 displays minimal inhibition against a panel of lysine methyltransferases, and no inhibition against type II and type III PRMTs.
GSK3368715 displays time-dependent inhibition of all the type I PRMTs except PRMT3, binds in the peptide site directly adjacent to the SAM pocket.
GSK3368715 demonstrated anti-proliferative activity against all cancer cell lines and primary patient samples; produces synergistic cancer cell growth inhibition when combined with PRMT5 inhibitor GSK3203591.
GSK3368715 induced an interferon gene signature, amplified responses to interferon and innate immune signaling pathways, and decreased expression of the immunosuppressive cytokine VEGF.

Physicochemical Properties

M.Wt 439.47
Formula C20H40Cl2N4O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N'-[[3-[4,4-bis(ethoxymethyl)cyclohexyl]-1H-pyrazol-4-yl]methyl]-N,N'-dimethyl-ethane-1,2-diamine;dihydrochloride

References

1. Fedoriw A, et al. Cancer Cell. 2019 Jul 8;36(1):100-114.e25.

2. Noto PB, et al. Sci Rep. 2020 Dec 17;10(1):22155.

3. Fedoriw A, et al. Cancer Immunol Res. 2022 Feb 18:canimm.0614.2021.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: